| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |